Joshua M. Hare
Expertise in
9
conditions

Dr. Joshua M. Hare

Cardiology
5555 Ponce De Leon Boulevard, Floor 3, 
Coral Gables, FL 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
9
conditions
5555 Ponce De Leon Boulevard, Floor 3, 
Coral Gables, FL 

Overview

Joshua Hare is a Cardiologist practicing medicine in Coral Gables, Florida.

Dr. Hare is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Heart Failure with Preserved Ejection Fraction (HFpEF), Dilated Cardiomyopathy (DCM), Bone Marrow Aspiration, and Hormone Replacement Therapy (HRT).

He is actively involved in clinical research, co-authoring 265 peer reviewed articles and participating in 8 clinical trials. Dr. Hare is currently accepting new patients.

Specialties

Cardiology

Licenses

Internal Medicine in MD

Fellowships

Johns Hopkins University School of Medicine, Internal Medicine - 1991
The Brigham and Women's Hospital, Cardiovascular Diseases - 1994

Languages Spoken

English
French
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Guardian Life Insurance Company
  • MEDICARE PDP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Icare Independent Care Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MetLife
  • PPO
Neighborhood
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

5555 Ponce De Leon Boulevard, Floor 3, Coral Gables, FL 33146

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease.
Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease.
Enrollment Status: Completed
Publish Date: June 16, 2026
Intervention Type: Other, Drug
Study Drug: Allogeneic Mesenchymal Human Stem Cells
Study Phase: Phase 1/Phase 2
Autologous Cardiac Stem Cell Injection in Patients With Hypoplastic Left Heart Syndrome: An Open Label Pilot Study.
Autologous Cardiac Stem Cell Injection in Patients With Hypoplastic Left Heart Syndrome: An Open Label Pilot Study.
Enrollment Status: Completed
Publish Date: January 23, 2026
Intervention Type: Biological
Study Drug: C-kit+ Cells
Study Phase: Phase 1
Lomecel-B Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase I/II Study (ELPIS)
Lomecel-B Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase I/II Study (ELPIS)
Enrollment Status: Unknown
Publish Date: October 04, 2023
Intervention Type: Biological
Study Drug: Longeveron Mesenchymal Stem Cells
Study Phase: Phase 1/Phase 2
A Phase I/II, Randomized, Placebo-controlled Comparative Study to Evaluate the Safety and Potential Efficacy of Intravenous Infusion of Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Bone Marrow (BM) Derived MSCs to Evaluate Cytokine Suppression in Patients With Chronic Inflammation Due to Metabolic Syndrome.
A Phase I/II, Randomized, Placebo-controlled Comparative Study to Evaluate the Safety and Potential Efficacy of Intravenous Infusion of Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Bone Marrow (BM) Derived MSCs to Evaluate Cytokine Suppression in Patients With Chronic Inflammation Due to Metabolic Syndrome.
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Biological, Other
Study Drugs: Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (UCMSC), Bone Marrow-Derived Mesenchymal Stem Cells (BMMSC)
Study Phase: Phase 1/Phase 2
A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Aging Frailty
A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Aging Frailty
Enrollment Status: Completed
Publish Date: July 14, 2021
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to EValuate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Injection in PAtieNts With FaceTogenic Back Pain
A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to EValuate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Injection in PAtieNts With FaceTogenic Back Pain
Enrollment Status: Withdrawn
Publish Date: October 20, 2020
Intervention Type: Drug, Biological
Study Phase: Phase 1/Phase 2
A Phase 1 Randomized, Double-blind, Placebo-controlled, Dose Escalation, Multicenter Study to Determine the Safety of Intravenous Ex-vivo Cultured Adult Human Mesenchymal Stem Cells (Provacel) Following Acute Myocardial Infarction
A Phase 1 Randomized, Double-blind, Placebo-controlled, Dose Escalation, Multicenter Study to Determine the Safety of Intravenous Ex-vivo Cultured Adult Human Mesenchymal Stem Cells (Provacel) Following Acute Myocardial Infarction
Enrollment Status: Completed
Publish Date: March 10, 2020
Intervention Type: Biological
Study Phase: Phase 1
A Phase I, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients With Treatment Resistant Depression.
A Phase I, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients With Treatment Resistant Depression.
Enrollment Status: Terminated
Publish Date: April 01, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 7 Less Clinical Trials

265 Total Publications

Cardiomyocyte-specific expression of HIF-1a mediates the cardioprotective effects of Growth Hormone Releasing Hormone (GHRH).
Cardiomyocyte-specific expression of HIF-1a mediates the cardioprotective effects of Growth Hormone Releasing Hormone (GHRH).
Journal: American journal of physiology. Heart and circulatory physiology
Published: August 01, 2026
Similar Doctors
Expertise in
20
conditions
Expertise in
20
conditions
Referral may be required
Before you request

Office

1400 NW 12th Ave Ste 4062, 
Miami,, FL 
 (6.9 miles away)
305-325-5511
Languages Spoken:
English
Accepting New Patients

Kyoko Soejima is a Cardiologist practicing medicine in Miami,, Florida. Dr. Soejima is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Arrhythmias, Ventricular Tachycardia, Sarcoidosis, Pacemaker Implantation, and Cardiac Ablation. Dr. Soejima is currently accepting new patients.

Expertise in
24
conditions
Dr. Jerry D. Estep
Cardiology | Interventional Cardiology
Expertise in
24
conditions
Dr. Jerry D. Estep
Cardiology | Interventional Cardiology
Referral may be required

Cleveland Clinic Florida

2950 Cleveland Clinic Blvd, 
Weston, FL 
 (26.0 miles away)
954-659-5000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Jerry Estep is a Cardiologist and an Interventional Cardiologist practicing medicine in Weston, Florida. Dr. Estep is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Heart Failure, Cardiac Amyloidosis, Cardiogenic Shock, Heart Transplant, and Endoscopy. Dr. Estep is currently accepting new patients.

Expertise in
24
conditions
Expertise in
24
conditions
Referral may be required
Before you request

Office

4300 Alton Rd, 
Miami Beach, FL 
 (11.1 miles away)
305-674-2690
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Christos Mihos is a Cardiologist practicing medicine in Miami Beach, Florida. He has been practicing medicine for over 17 years. Dr. Mihos is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Mitral Valve Regurgitation, Endocarditis, Aortic Regurgitation, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG). Dr. Mihos is currently accepting new patients.

Frequently Asked Questions about Dr. Joshua M. Hare

How do I make an appointment with Dr. Joshua M. Hare?

You can book an appointment with Dr. Joshua M. Hare by calling their office at 305-243-5554. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Joshua M. Hare a top-rated expert for Cardiomyopathy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joshua M. Hare is classified as an Distinguished expert for Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Joshua M. Hare specialize in?

While Dr. Joshua M. Hare is a Cardiology, they have specific expertise in Cardiomyopathy, Heart Failure with Preserved Ejection Fraction (HFpEF), and Dilated Cardiomyopathy (DCM). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Joshua M. Hare participate in research or clinical trials?

Yes. Dr. Joshua M. Hare has published 265 articles and abstracts on conditions like Cardiomyopathy. You can view a list of Dr. Joshua M. Hare's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Joshua M. Hare accept my insurance?

Dr. Joshua M. Hare accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 305-243-5554 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hare's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile